Using the nanoparticles, which resemble tiny semiconductors used in electronics, University of Colorado Boulder researchers have been able to specifically target superbug bacteria that are resistant to other forms of therapy.
“Antibiotics are not just a baseline treatment for bacterial infections, but HIV and cancer as well,” Anushree Chatterjee, an assistant professor in the Department of Chemical and Biological Engineering at CU-Boulder and a senior author of the study, said in a news release. “Failure to develop effective treatments for drug-resistant strains is not an option, and that’s what this technology moves closer to solving.”
More articles on infection control:
CDC, American College of Physicians issue new guidelines for antibiotic prescription
2015 was record year for transplant numbers in the US
How clean is clean-shaven? Study finds beardless healthcare workers carry more bacteria on their faces
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.